Novasun Life Science Private Limited

Nvron Life Science Ltd. began in 2013 with a vision to touch 1 billion lives globally. Over the years, they have made significant strides through rigorous scientific research, unparalleled quality assurance, and impactful community initiatives. They evolved into a public limited entity in 2015, strategically positioning themselves in the challenging landscape of pharmaceuticals. Their passion for medical innovation became their driving force, with a foray into Cardiology and Critical Care, followed by expanding clinical options in cardiac and diabetic care, and a new era in general medicine. They also launched specialized therapeutics and a Gynecology Division. In 2019, they amplified their infrastructural capabilities by establishing a Hygiene Product Manufacturing facility in Coimbatore and their in-house R&D department began to blossom. During the COVID-19 pandemic, they swiftly adapted, manufacturing essential hygiene products. Recent milestones include receiving pharmaceutical manufacturing approval in Himachal Pradesh's Bilaspur district in 2022 and their presence as an exhibition partner at PharmaMac South 2023.